Babylon Health

Health Tech

Babylon Health’s CEO ‘Should Spend Some Time With Elizabeth Holmes’

U.K. doctor David Watkins has been a public critic of Babylon Health and its AI technology for years, during which has received anonymous emails from Babylon employees who shared his concerns but feared to speak out publicly. After Babylon collapsed, a former employee publicly declared that the AI engine was indeed faulty. As a longtime skeptic of Babylon's claims surrounding its technology, Watkins said that Ali Parsa, the company's CEO, shouldn’t be treated any differently to Elizabeth Holmes.

presented by
Health Tech

Teladoc can recover by looking at what Amazon did 20 years ago, Babylon Health CEO says

With the recent disclosure of its Q2 financial results, Teladoc’s losses have swelled to nearly $10 billion in the first half of 2022. Ali Parsa, CEO of competitor Babylon Health, said Teladoc can look at what Amazon did 20 years ago as an example of how to navigate an unforgiving economic environment, recommending the company reorganize its expenditures to ensure capital is allocated to areas that will differentiate it from its competitors.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.